By Connor Hart
DSS has named Jason Grady as its interim chief executive officer.
Grady assumed the role on Friday succeeding Frank Heuszel, who left to transition to a leadership role within one of its former subsidiaries, the New York paper products company said on Monday.
Grady has held various positions at DSS including chief executive officer and director of DSS Biohealth.
Heuszel will transition to a leadership role at Impact Biomedical, which works to discover, confirm and patent science and technologies in human healthcare and wellness.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
August 26, 2024 16:24 ET (20:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments